Concepedia

M. Namjoshi

MN

Statistics

Publications

14

Citations

736

H-Index

12

Active since

2001

Affiliations

Eli Lilly (United States)(Current)

Harvard University

Analysis Group (United States)

Novartis (Switzerland)

McLean Hospital

M. Namjoshi is an author at Eli Lilly (United States) specializing in psychiatry, psychiatric pharmacotherapy, and psychopharmacology.

Publications per year

2001–2022

14

Publications

14

A 12-Week, Double-blind Comparison of Olanzapine vs Haloperidol in the Treatment of Acute Mania

Mauricio Tohen, Joseph F. Goldberg, J.-M. Azorin et al. · Archives of General Psychiatry · 2003 · 230 citations

, , +13

Long-Term Olanzapine Therapy in the Treatment of Bipolar I Disorder

T.M. Sanger, Starr L. Grundy, P. Joseph Gibson et al. · The Journal of Clinical Psychiatry · 2001 · 99 citations

, , +15

Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status

Lizheng Shi, M. Namjoshi, F. Zhang et al. · International Clinical Psychopharmacology · 2002 · 67 citations

, , +14

Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: Secondary analyses of a double-blind, placebo-controlled, randomized clinical trial

Lizheng Shi, M. Namjoshi, Ralph Swindle et al. · Clinical Therapeutics · 2004 · 60 citations

, , +11

Economic Evaluation of Denosumab Compared with Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients with Bone Metastases

Jipan Xie, M. Namjoshi, Eric Q. Wu et al. · Journal of Managed Care Pharmacy · 2011 · 58 citations · Full text

, , +17

1–5 of 14